 |
 
 
 
 
|
|
 |
|
| |
 |
A
randomized, double-blind, placebo-controlled study to
test the efficacy of COLD-EEZE® lozenges in reducing
the duration and severity of the common cold.
From the Cleveland Clinic Foundation Study, Cleveland,
Ohio, 1996.
View Abstract
| View
Study |
|
|
|
Zinc
Gluconate and the Common Cold
A Controlled Clinical Study. The Journal of International
Medical Research,
Volume 20, number 3, June 1992. J C Godfrey, B Conant
Sloane, D S Smith,
J H Turco, N Mercer and N J Godfrey.
View Abstract |
|
|
|
An
open-label, single-center, phase IV clinical study of
the effectiveness of zinc gluconate glycine lozenges (COLD-EEZE®)
in reducing the duration and symptoms of the common cold
in school-aged subjects.
McElroy BH, Miller SP. Am J Ther. 2003 Sep-Oct;10(5):324-9.
View Abstract
| View Study |
|
|
|
Effectiveness
of zinc gluconate glycine lozenges (COLD-EEZE®) against
the common cold in school-aged subjects: a retrospective
chart review.
McElroy BH, Miller SP. Am J Ther. 2002 Nov-Dec;9(6):472-5.
View Abstract
| View Study |
|
|
|
American
Journal of Therapeutics
Sugar-Free Zinc Gluconate Glycine Lozenges (COLD-EEZE®)
Do Not Adversely Affect Glucose Control in Patients with
Type 1 or Type 2 Diabetes Mellitus. American Journal of
Therapeutics, Volume 8, number 4, July 2001. Sherwyn L.
Schwartz, Jerome S. Fischer and Mark S. Kipnes.
View Abstract | View
Study |
|
 |
|
|
|
|
|
